TWP
DGX icon

Tower Wealth Partners’s Quest Diagnostics DGX Stock Holding History

Tower Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+1,006
New +$197K 0.11% 92

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Tower Wealth Partners's DGX Position: Q2 2026 in Review

Tower Wealth Partners opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,006 shares worth $213K. The stake represents 0.11% of the portfolio and ranks #92 among its holdings.

1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Tower Wealth Partners held 1,006 shares of Quest Diagnostics worth $213K as of Q2 2026.
  • Quest Diagnostics was a new Tower Wealth Partners position in Q2 2026.
  • Quest Diagnostics made up 0.11% of Tower Wealth Partners's portfolio in Q2 2026, its #92 holding.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Tower Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.